Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Harris, AL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 354 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fox, SB; Harris, AL
      Diagnostic and prognostic significance of tumor angiogenesis

      NEW ANGIOTHERAPY
    2. Knowles, HJ; Harris, AL
      Hypoxia and oxidative stress in breast cancer - Hypoxia and tumourigenesis

      BREAST CANCER RESEARCH
    3. Huminiecki, L; Chan, HY; Liu, S; Poulsom, R; Stamp, G; Harris, AL; Bicknell, R
      Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection (vol 7, pg 255, 2001)

      MOLECULAR HUMAN REPRODUCTION
    4. Huminiecki, L; Chan, HY; Lui, S; Poulsom, R; Stamp, G; Harris, AL; Bicknell, R
      Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection

      MOLECULAR HUMAN REPRODUCTION
    5. Levitt, NC; Eskens, FALM; O'Byrne, KJ; Propper, DJ; Denis, LJ; Owen, SJ; Choi, L; Foekens, JA; Wilner, S; Wood, JM; Nakajima, M; Talbot, DC; Steward, WP; Harris, AL; Verweij, J
      Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer

      CLINICAL CANCER RESEARCH
    6. Harris, AL; Reusch, P; Barleon, B; Hang, C; Dobbs, N; Marme, D
      Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy

      CLINICAL CANCER RESEARCH
    7. Jones, A; Fujiyama, C; Blanche, C; Moore, JW; Fuggle, S; Cranston, D; Bicknell, R; Harris, AL
      Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines

      CLINICAL CANCER RESEARCH
    8. Qin, CH; Wilson, C; Blancher, C; Taylor, M; Safe, S; Harris, AL
      Association of ARNT splice variants with estrogen receptor-negative breastcancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis

      CLINICAL CANCER RESEARCH
    9. Currie, MJ; Gunningham, SP; Han, C; Scott, PAE; Robinson, BA; Harris, AL; Fox, SB
      Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling

      CLINICAL CANCER RESEARCH
    10. Koukourakis, MI; Giatromanolaki, A; Sivridis, E; Simopoulos, K; Pastorek, J; Wykoff, CC; Gatter, KC; Harris, AL
      Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy

      CLINICAL CANCER RESEARCH
    11. Kakolyris, S; Giatromanolaki, A; Koukourakis, M; Powis, G; Souglakos, J; Sivridis, E; Georgoulias, V; Gatter, KC; Harris, AL
      Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    12. Winters, ZE; Hunt, NC; Bradburn, MJ; Royds, JA; Turley, H; Harris, AL; Norbury, CJ
      Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer: association with prognosis

      EUROPEAN JOURNAL OF CANCER
    13. Mackay, HJ; McInnes, A; Paul, J; Raby, N; Lofts, FJ; McDonald, AC; Soukop, M; Fullarton, GM; Harris, AL; Garcia-Vargas, J; Evans, TRJ
      A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma

      ANNALS OF ONCOLOGY
    14. Propper, DJ; McDonald, AC; Man, A; Thavasu, P; Balkwill, F; Braybrooke, JP; Caponigro, F; Graf, P; Dutreix, C; Blackie, R; Kaye, SB; Ganesan, TS; Talbot, DC; Harris, AL; Twelves, C
      Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C

      JOURNAL OF CLINICAL ONCOLOGY
    15. Chia, SK; Wykoff, CC; Watson, PH; Han, C; Leek, RD; Pastorek, J; Gatter, KC; Ratcliffe, P; Harris, AL
      Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    16. Koukourakis, MI; Giatromanolaki, A; Kakolyris, S; Sivridis, E; Georgoulias, V; Funtzilas, G; Hickson, ID; Gatter, KC; Harris, AL
      Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/REF-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    17. Fox, SB; Taylor, M; Grondahl-Hansen, J; Kakolyris, S; Gatter, KC; Harris, AL
      Plasminogen activator inhibitor-I as a measure of vascular remodelling in breast cancer

      JOURNAL OF PATHOLOGY
    18. Giatromanolaki, A; Sivridis, E; Atanassou, N; Zois, E; Thorpe, PE; Brekken, RA; Gatter, KC; Harris, AL; Koukourakis, IM; Koukourakis, MI
      The angiogenic pathway 'vascular endothelial growth factor/flk-I (KDR)-receptor' in rheumatoid arthritis and osteoarthritis

      JOURNAL OF PATHOLOGY
    19. Gunningham, SP; Currie, MJ; Han, C; Robinson, BA; Scott, PAE; Harris, AL; Fox, SB
      VEGF-B expression in human primary breast cancers is associated with lymphnode metastasis but not angiogenesis

      JOURNAL OF PATHOLOGY
    20. Gunningham, SP; Currie, MJ; Han, C; Turner, K; Scott, PAE; Robinson, BA; Harris, AL; Fox, SB
      Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: Regulation by the von Hippel-Lindau gene and hypoxia

      CANCER RESEARCH
    21. Koukourakis, MI; Giatromanolaki, A; Skarlatos, J; Corti, L; Blandamura, S; Piazza, M; Gatter, KC; Harris, AL
      Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy

      CANCER RESEARCH
    22. Giatromanolaki, A; Koukourakis, MI; Sivridis, E; Pastorek, J; Wykoff, CC; Gatter, KC; Harris, AL
      Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenicpathways and independently to poor outcome in non-small cell lung cancer

      CANCER RESEARCH
    23. Blancher, C; Moore, JW; Robertson, N; Harris, AL
      Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1 alpha, HIF-2 alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3 '-kinase/Akt signaling pathway

      CANCER RESEARCH
    24. Sowter, HM; Ratcliffe, PJ; Watson, P; Greenberg, AH; Harris, AL
      HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors

      CANCER RESEARCH
    25. Loncaster, JA; Harris, AL; Davidson, SE; Logue, JP; Hunter, RD; Wycoff, CC; Pastorek, J; Ratcliffe, PJ; Stratford, IJ; West, CML
      Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker ofhypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix

      CANCER RESEARCH
    26. Beasley, NJP; Wykoff, CC; Watson, PH; Leek, R; Turley, H; Gatter, K; Pastorek, J; Cox, GJ; Ratcliffe, P; Harris, AL
      Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density

      CANCER RESEARCH
    27. Giatromanolaki, A; Sivridis, E; Brekken, R; Thorpe, PE; Anastasiadis, P; Gatter, KC; Harris, AL; Koukourakis, MI
      The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma - Prognostic and therapeutic implications

      CANCER
    28. Giatromanolaki, A; Koukourakis, MI; Sivridis, E; Turley, H; Talks, K; Pezzella, F; Gatter, KC; Harris, AL
      Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

      BRITISH JOURNAL OF CANCER
    29. Fujiyama, C; Jones, A; Fuggle, S; Bicknell, R; Cranston, D; Harris, AL
      Human bladder cancer invasion model using rat bladder in vitro and its useto test mechanisms and therapeutic inhibitors of invasion

      BRITISH JOURNAL OF CANCER
    30. Clarke, K; Smith, K; Gullick, WJ; Harris, AL
      Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway

      BRITISH JOURNAL OF CANCER
    31. Wykoff, CC; Beasley, N; Watson, PH; Campo, L; Chia, SK; English, R; Pastorek, J; Sly, WS; Ratcliffe, P; Harris, AL
      Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast

      AMERICAN JOURNAL OF PATHOLOGY
    32. Harris, AL; Bevans, CG
      Exploring hemichannel permeability in vitro

      CONNEXIN METHODS AND PROTOCOLS
    33. Koukourakis, MI; Giatromanolaki, A; Guddo, F; Kaklamanis, L; Vignola, M; Kakolyris, S; Turley, H; Georgoulias, V; Bonsignore, G; Gatter, KC; Harris, AL
      c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer

      JOURNAL OF IMMUNOTHERAPY
    34. Jones, A; Fujiyama, C; Turner, K; Fuggle, S; Cranston, D; Turley, H; Valtola, R; Bicknell, R; Harris, AL
      Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis

      BJU INTERNATIONAL
    35. Jones, A; Fujiyama, C; Turner, K; Fuggle, S; Cranston, D; Bicknell, R; Harris, AL
      Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer

      BJU INTERNATIONAL
    36. Giatromanolaki, A; Koukourakis, MI; Sivridis, E; O'Byrne, K; Cox, G; Thorpe, PE; Gatter, KC; Harris, AL
      Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways

      CLINICAL CANCER RESEARCH
    37. Koukourakis, MI; Giatromanolaki, A; Fountzilas, G; Sivridis, E; Gatter, KC; Harris, AL
      Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy

      CLINICAL CANCER RESEARCH
    38. Eskens, FALM; Levitt, NC; Sparreboom, A; Choi, L; Mather, R; Verweij, J; Harris, AL
      Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor

      CLINICAL CANCER RESEARCH
    39. Braybrooke, JP; O'Byrne, KJ; Propper, DJ; Blann, A; Saunders, M; Dobbs, N; Han, C; Woodhull, J; Mitchell, K; Crew, J; Smith, K; Stephens, R; Ganesan, TS; Talbot, DC; Harris, AL
      A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis

      CLINICAL CANCER RESEARCH
    40. Gunningham, SP; Currie, MJ; Han, C; Robinson, BA; Scott, PAE; Harris, AL; Fox, SB
      The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers

      CLINICAL CANCER RESEARCH
    41. Kakolyris, SA; Kaklamanis, LG; Koukourakis, MJ; Giatromanolaki, A; Rousomoustakaki, M; Souglakos, JC; Reppa, DK; Georgoulias, VA; Gatter, KC; Harris, AL
      Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence

      ONCOLOGY RESEARCH
    42. Giatromanolaki, A; Koukourakis, MI; Stathopoulos, GP; Kapsoritakis, A; Paspatis, G; Kakolyris, S; Sivridis, E; Georgoulias, V; Harris, AL; Gatter, KC
      Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer

      ONCOLOGY RESEARCH
    43. O'Byrne, KJ; Dalgleish, AG; Browning, MJ; Steward, WP; Harris, AL
      The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease

      EUROPEAN JOURNAL OF CANCER
    44. Deplanque, G; Harris, AL
      Anti-angiogenic agents: clinical trial design and therapies in development

      EUROPEAN JOURNAL OF CANCER
    45. Wykoff, CC; Pugh, CW; Maxwell, PH; Harris, AL; Ratcliffe, PJ
      Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

      ONCOGENE
    46. Braybrooke, JP; Vallis, KA; Houlbrook, S; Rockett, H; Ellmen, J; Anttila, M; Ganesan, TS; Harris, AL; Talbot, DC
      Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    47. Braybrooke, JP; Houlbrook, S; Crawley, JE; Propper, DJ; O'Byrne, KJ; Stratford, IJ; Harris, AL; Shuker, DEG; Talbot, DC
      Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    48. Dhar, L; Schnoes, MG; Katz, HE; Hale, A; Schilling, ML; Harris, AL
      Photopolymers for digital holographic data storage

      HOLOGRAPHIC DATA STORAGE
    49. Wang, SW; Toda, T; MacCallum, R; Harris, AL; Norbury, C
      Cid1, a fission yeast protein required for S-M checkpoint control when DNApolymerase delta or epsilon is inactivated

      MOLECULAR AND CELLULAR BIOLOGY
    50. Giatromanolaki, A; Koukourakis, MI; Sivridis, E; Thorpe, PE; Brekken, RA; Konstantinos, S; Fountzilas, G; Gatter, KC; Harris, AL
      Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas

      CLINICAL & EXPERIMENTAL METASTASIS
    51. Grant, CJ; Harris, AL
      The kinematic and metamorphic history of the Sgurr Beag Thrust, Ross-shire, NW Scotland

      JOURNAL OF STRUCTURAL GEOLOGY
    52. Pezzella, F; Manzotti, M; Di Bacco, A; Viale, G; Nicholson, AG; Price, R; Ratcliffe, C; Pastorino, U; Gatter, KC; Harris, AL; Altman, DG; Pilotti, S; Veronesi, U
      Evidence for novel non-angiogenic pathway in breast-cancer metastasis

      LANCET
    53. Matthews, MJ; Harris, AL; Bruce, AJ; Cardillo, MJ
      Characterization of phosphosilicate thin films using confocal Raman microscopy

      REVIEW OF SCIENTIFIC INSTRUMENTS
    54. Giatromanolaki, A; Koukourakis, MI; Sivridis, E; O'Byrne, K; Gatter, KC; Harris, AL
      'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer

      JOURNAL OF PATHOLOGY
    55. Lewis, JS; Landers, RJ; Underwood, JCE; Harris, AL; Lewis, CE
      Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas

      JOURNAL OF PATHOLOGY
    56. Leek, RD; Hunt, NC; Landers, RJ; Lewis, CE; Royds, JA; Harris, AL
      Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer

      JOURNAL OF PATHOLOGY
    57. Dunbar, PR; Smith, CL; Chao, D; Salio, M; Shepherd, D; Mirza, F; Lipp, M; Lanzavecchia, A; Sallusto, F; Evans, A; Russell-Jones, R; Harris, AL; Cerundolo, V
      A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response

      JOURNAL OF IMMUNOLOGY
    58. Turner, HE; Nagy, Z; Gatter, KC; Esiri, MM; Harris, AL; Wass, JAH
      Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome

      JOURNAL OF ENDOCRINOLOGY
    59. Sivridis, E; Giatromanolaki, A; Koukourakis, MI; Bicknell, R; Harris, AL; Gatter, KC
      Thymidine phosphorylase expression in normal and hyperplastic endometrium

      JOURNAL OF CLINICAL PATHOLOGY
    60. Turner, HE; Nagy, Z; Esiri, MM; Harris, AL; Wass, JAH
      Role of matrix metalloproteinase 9 in pituitary tumor behavior

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    61. Turner, HE; Nagy, Z; Gatter, KC; Esiri, MM; Harris, AL; Wass, JAH
      Angiogenesis in pituitary adenomas and the normal pituitary gland

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    62. Rose, PTS; Harris, AL
      Evidence for the Lower Palaeozoic age of the Tay Nappe: the timing and nature of Grampian events in the Scottish Highland sector of the Laurentian Margin

      JOURNAL OF THE GEOLOGICAL SOCIETY
    63. Wykoff, CC; Beasley, NJP; Watson, PH; Turner, KJ; Pastorek, J; Sibtain, A; Wilson, GD; Turley, H; Talks, KL; Maxwell, PH; Pugh, CW; Ratcliffe, PJ; Harris, AL
      Hypoxia-inducible expression of tumor-associated carbonic anhydrases

      CANCER RESEARCH
    64. Blancher, C; Moore, JW; Talks, KL; Houlbrook, S; Harris, AL
      Relationship of hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines

      CANCER RESEARCH
    65. Brown, NS; Jones, A; Fujiyama, C; Harris, AL; Bicknell, R
      Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors

      CANCER RESEARCH
    66. Winsey, SL; Haldar, NA; Marsh, HP; Bunce, M; Marshall, SE; Harris, AL; Wojnarowska, F; Welsh, KI
      A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer

      CANCER RESEARCH
    67. Koukourakis, MI; Giatromanolaki, A; Thorpe, PE; Brekken, RA; Sivridis, E; Kakolyris, S; Georgoulias, V; Gatter, KC; Harris, AL
      Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer

      CANCER RESEARCH
    68. Talks, KL; Harris, AL
      Current status of antiangiogenic factors

      BRITISH JOURNAL OF HAEMATOLOGY
    69. Braybrooke, JP; Propper, DJ; O'Byrne, KJ; Koukourakis, MI; Patterson, AV; Houlbrook, S; Love, SD; Varcoe, S; Taylor, M; Ganesan, TS; Talbot, DC; Harris, AL
      Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid andinterferon alpha

      BRITISH JOURNAL OF CANCER
    70. Zhang, HT; Scott, PAE; Morbidelli, L; Peak, S; Moore, J; Turley, H; Harris, AL; Ziche, M; Bicknell, R
      The 121 amino acid isoform of vascular endothelial growth factor is move strongly tumorigenic than other splice variants in vivo

      BRITISH JOURNAL OF CANCER
    71. O'Byrne, KJ; Koukourakis, MI; Giatromanolaki, A; Cox, G; Turley, H; Steward, WP; Gatter, K; Harris, AL
      Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer

      BRITISH JOURNAL OF CANCER
    72. Turner, HE; Nagy, Z; Gatter, KC; Esiri, MM; Wass, JAH; Harris, AL
      Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour

      BRITISH JOURNAL OF CANCER
    73. Kakolyris, S; Fox, SB; Koukourakis, M; Giatromanolaki, A; Brown, N; Leek, RD; Taylor, M; Leigh, IM; Gatter, KC; Harris, AL
      Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39

      BRITISH JOURNAL OF CANCER
    74. Saunders, MP; Patterson, AV; Chinje, EC; Harris, AL; Stratford, IJ
      NADPH : cytochrome C (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line

      BRITISH JOURNAL OF CANCER
    75. Propper, DJ; Braybrooke, JP; Levitt, NC; O'Byrne, KO; Christodoulos, K; Han, C; Talbot, DC; Ganesan, TS; Harris, AL
      Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine

      BRITISH JOURNAL OF CANCER
    76. Propper, DJ; Levitt, NC; O'Byrne, K; Braybrooke, JP; Talbot, DC; Ganesan, TS; Thompson, CH; Rajagopalan, B; Littlewood, TJ; Dixon, RM; Harris, AL
      Phase II study of the oxygen saturation curve left shifting agent BW12C incombination with the hypoxia activated drug mitomycin C in advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    77. O'Byrne, KJ; Dobbs, N; Harris, AL
      Serum vascular endothelial growth factor load and interleukin-6 in cancer patients

      BRITISH JOURNAL OF CANCER
    78. Crew, JP; Fuggle, S; Bicknell, R; Cranston, DW; de Benedetti, A; Harris, AL
      Eukaryotic initiation factor-4E in superficial and muscle invasive bladdercancer and its correlation with vascular endothelial growth factor expression and tumour progression

      BRITISH JOURNAL OF CANCER
    79. Saunders, MP; Jaffar, M; Patterson, AV; Nolan, J; Naylor, MA; Phillips, RM; Harris, AL; Stratford, IJ
      The relative importance of NADPH: Cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions

      BIOCHEMICAL PHARMACOLOGY
    80. Talks, KL; Turley, H; Gatter, KC; Maxwell, PH; Pugh, CW; Ratcliffe, PJ; Harris, AL
      The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages

      AMERICAN JOURNAL OF PATHOLOGY
    81. Fox, SB; Gatter, KC; Leek, RD; Harris, AL; Chew, KL; Mayall, BH; Moore, DH
      More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    82. De Benedetti, A; Harris, AL
      eIF4E expression in tumors: its possible role in progression of malignancies

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    83. Patterson, A; Harris, AL
      Molecular chemotherapy for breast cancer

      DRUGS & AGING
    84. Pullen, SH; Studer-Martinez, SL; Edington, MD; Harris, AL; Long, A; Baldwin, SW; Staab, HA; Simon, JD
      Comparison of the photoinduced electron transfer reaction in a rigid cyclophane and its corresponding bimolecular donor/acceptor complex

      JOURNAL OF PHYSICAL CHEMISTRY A
    85. Propper, DJ; Saunders, MP; Salisbury, AJ; Long, L; O'Byrne, KJ; Braybrooke, JP; Dowsett, M; Taylor, M; Talbot, DC; Ganesan, TS; Harris, AL
      Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: Toxicity, hormonal, and immunological effects

      CLINICAL CANCER RESEARCH
    86. Macaulay, VM; O'Byrne, KJ; Saunders, MP; Braybrooke, JP; Long, L; Gleeson, F; Mason, CS; Harris, AL; Brown, P; Talbot, DC
      Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions

      CLINICAL CANCER RESEARCH
    87. Koukourakis, MI; Flordellis, CS; Giatromanolaki, A; Koukouraki, S; Kapsoritakis, A; Potamianos, S; Retalis, G; Sivridis, E; Salsaa, B; Harris, AL; Maragoudakis, MI
      Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis

      CLINICAL CANCER RESEARCH
    88. Giatromanolaki, A; Sivridis, E; Koukourakis, MI; Georgoulias, V; Gatter, KC; Harris, AL
      Intratumoral angiogenesis: A new prognostic indicator for stage I endometrial adenocarcinomas?

      ONCOLOGY RESEARCH
    89. Ongkeko, WM; Wang, XQ; Siu, WY; Lau, AWS; Yamashita, K; Harris, AL; Cox, LS; Poon, RYC
      MDM2 and MDMX bind and stabilize the p53-related protein p73

      CURRENT BIOLOGY
    90. Philip, PA; Rea, D; Mitchell, K; Carmichael, J; Harris, AL; Talbot, DC
      A pilot study of increasing dose intensity of epirubicin and ifosfamide inpatients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor

      CLINICAL ONCOLOGY
    91. Propper, DJ; Braybrooke, JP; Taylor, DJ; Lodi, R; Styles, P; Cramer, JA; Collins, WCJ; Levitt, NC; Talbot, DC; Ganesan, TS; Harris, AL
      Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours

      ANNALS OF ONCOLOGY
    92. O'Byrne, KJ; Philip, PA; Propper, DJ; Braybrooke, JP; Saunders, MP; Bates, NP; Taylor, MA; Madigan, D; Ganesan, TS; Talbot, DC; Harris, AL
      A phase II study of the modulation of 5-fluorouracil and folinic acid withhigh-dose infusional hydroxyurea in metastatic colorectal carcinoma

      ANNALS OF ONCOLOGY
    93. Smith, K; Fox, SB; Whitehouse, R; Taylor, M; Greenall, M; Clarke, J; Harris, AL
      Upregulation of basic fibroblast growth factor in breast carcinoma and itsrelationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival

      ANNALS OF ONCOLOGY
    94. Schilling, ML; Colvin, VL; Dhar, L; Harris, AL; Schilling, FC; Katz, HE; Wysocki, T; Hale, A; Blyler, LL; Boyd, C
      Acrylate oligomer-based photopolymers for optical storage applications

      CHEMISTRY OF MATERIALS
    95. Lewis, JS; Lee, JA; Underwood, JCE; Harris, AL; Lewis, CE
      Macrophage responses to hypoxia, relevance to disease mechanisms

      JOURNAL OF LEUKOCYTE BIOLOGY
    96. Arapandoni-Dadioti, P; Giatromanolaki, A; Trihia, H; Harris, AL; Koukourakis, MI
      Angiogenesis in ductal breast carcinoma. Comparison of microvessel densitybetween primary tumour and lymph node metastasis

      CANCER LETTERS
    97. Koukourakis, MI; Giatromanolaki, A; O'Byrne, KJ; Cox, J; Krammer, B; Gatter, KC; Harris, AL
      bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer

      CLINICAL & EXPERIMENTAL METASTASIS
    98. Sivridis, E; Giatromanolaki, A; Koukourakis, MI; Bicknell, R; Harris, AL; Gatter, KC
      Thymidine phosphorylase expression in endometrial carcinomas

      CLINICAL & EXPERIMENTAL METASTASIS
    99. O'Byrne, KJ; Dobbs, N; Propper, D; Smith, K; Harris, AL
      Vascular endothelial growth factor platelet counts, and prognosis in renalcancer

      LANCET
    100. Crew, JP; O'Brien, T; Bicknell, R; Fuggle, S; Cranston, D; Harris, AL
      Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates

      JOURNAL OF UROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 20:13:03